What are the major opportunities in the Nuclear Medicine Radioisotopes market? What are the strategies for the Nuclear Medicine Radioisotopes market?

For detailed insights on the major opportunities and strategies in the Nuclear Medicine Radioisotopes market, Read More

How does the Nuclear Medicine Radioisotopes market relate to the overall economy and other similar markets?

For detailed insights on Nuclear Medicine Radioisotopes's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Nuclear Medicine Radioisotopes market growth? SWOT analysis of the Nuclear Medicine Radioisotopes market.

For detailed insights on the key dynamics influencing the Nuclear Medicine Radioisotopes market growth and SWOT analysis of the Nuclear Medicine Radioisotopes industry, Read More

Nuclear Medicine Radioisotopes Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Nuclear Medicine Radioisotopes Market Report 2026

Name: Nuclear Medicine Radioisotopes Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types), By Application (Oncology, Cardiology, Thyroid, Neurology, Other Applications), By End-User (Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Nuclear Medicine Radioisotopes Market Overview

• Nuclear Medicine Radioisotopes market size has reached to $8.85 billion in 2025

• Expected to grow to $12.75 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%

• Growth Driver: Rising Cases Of Cardiovascular Diseases Is Driving The Growth Of The Nuclear Medicine Radioisotopes

• Market Trend: Next-Generation Radiopharmaceuticals Accelerate The Future Of Precision Medicine

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nuclear Medicine Radioisotopes Market?

Nuclear medicine radioisotopes are radioactive isotopes used in nuclear medicine to diagnose, treat, and research various medical conditions. These isotopes emit radiation detected and imaged by specialized equipment or deliver therapeutic doses of radiation to targeted tissues. Nuclear medicine radioisotopes are essential in modern medical diagnostics and treatments, providing critical information and therapeutic options that improve patient outcomes.

The main types of nuclear medicine radioisotopes are technetium-99m (Tc-99m), thallium-201 (Tl-201), iodine (I-123), fluorine-18, rubidium-82 (Rb-82), iodine-131 (I-131), lutetium-177 (Lu-177), radium-223 (Ra-223) and alpharadin, actinium-225 (Ac-225), and others. Technetium-99m (Tc-99m) is a radioactive isotope widely used in nuclear medicine imaging procedures to diagnose various medical conditions. Applications such as oncology, cardiology, thyroid, neurology, and others for end users such as hospitals, diagnostic centers, specialty clinics, education and research institutes, and others.

Nuclear Medicine Radioisotopes Market Global Report 2026 Market Report bar graph

What Is The Nuclear Medicine Radioisotopes Market Size and Share 2026?

The nuclear medicine radioisotopes market size has grown strongly in recent years. It will grow from $8.85 billion in 2025 to $9.58 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to widespread use of technetium-99m in diagnostic imaging, growing adoption of nuclear cardiology procedures, increasing prevalence of cancer and thyroid disorders, expansion of hospital-based nuclear medicine departments, early clinical success of radioisotope-based therapies.

What Is The Nuclear Medicine Radioisotopes Market Growth Forecast?

The nuclear medicine radioisotopes market size is expected to see strong growth in the next few years. It will grow to $12.75 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to rising demand for personalized cancer treatment, increasing use of lutetium-177 and actinium-225 therapies, expansion of PET imaging infrastructure, growing investments in cyclotron and reactor facilities, rising adoption of nuclear medicine in emerging economies. Major trends in the forecast period include rising adoption of theranostics in oncology care, growing demand for PET and SPECT imaging procedures, increased use of targeted alpha and beta emitters, expansion of nuclear medicine in cardiology and neurology, strengthening focus on domestic radioisotope production.

Book your 30 minutes free consultation with our research experts

Global Nuclear Medicine Radioisotopes Market Segmentation

1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types

2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users

Subsegments:

1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)

2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging

3) By Iodine-123 (I-123): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)

4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging

5) By Rubidium-82 (Rb-82): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging

6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment

7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment

8) By Radium-223 (Ra-223): Ra-223 Dichloride (Xofigo), Alpharadin For Bone Metastasis Treatment

9) By Alpharadin (Radium-223 Alpha Emitters): Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)

10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)

What Is The Driver Of The Nuclear Medicine Radioisotopes Market?

The rising cases of cardiovascular diseases are expected to propel the growth of the nuclear medicine radioisotope market going forward. Cardiovascular diseases refer to a group of diseases that affect the heart and blood vessels. The rising cases of cardiovascular diseases are due to sedentary lifestyles, poor dietary habits, increasing rates of obesity, and aging populations. The nuclear medicine radioisotopes are invaluable in diagnosing, evaluating, and managing cardiovascular diseases with detailed insights into cardiac function, perfusion, and tissue viability, which are essential for accurate diagnosis and effective treatment planning. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising cases of cardiovascular diseases are driving the growth of the nuclear medicine radioisotope industry.

Key Players In The Global Nuclear Medicine Radioisotopes Market

Major companies operating in the nuclear medicine radioisotopes market are Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczacibasi-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation

Global Nuclear Medicine Radioisotopes Market Trends and Insights

Major companies operating in the nuclear medicine radioisotopes market are focusing on developing innovative solutions such as next-generation theranostic radiopharmaceuticals to enhance precision imaging and targeted treatment. Next-generation theranostic radiopharmaceuticals are advanced radioactive agents designed to both detect and precisely treat diseases by targeting specific cells in the body with high accuracy. For instance, in November 2025, the University of California, a US-based research university, launched a completely independent Department of Nuclear Medicine & Theranostics, rather than keeping nuclear medicine under a broader radiology umbrella. This new department aims to accelerate the integration of advanced imaging and targeted radiopharmaceutical therapies. It also strengthens research, education, and clinical programs to advance precision medicine and drive innovations in theranostic treatments.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Nuclear Medicine Radioisotopes Market?

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS for an undisclosed amount. With this acquisition, Telix Pharmaceuticals aimed to strengthen its nuclear medicine capabilities, optimize production procedures, and broaden its range of diagnostic and therapeutic radiopharmaceuticals. ARTMS is a Canada-based company providing novel radioisotope technology and is involved in nuclear medicine radioisotopes.

Regional Insights

North America was the largest region in the nuclear medicine radioisotopes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nuclear Medicine Radioisotopes Market?

The nuclear medicine radioisotopes market consists of sales of yttrium-90, indium-111, carbon-11, samarium-153, and strontium-89. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nuclear Medicine Radioisotopes Market Report 2026?

The nuclear medicine radioisotopes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine radioisotopes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Nuclear Medicine Radioisotopes Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$9.58 billion
Revenue Forecast In 2035	$12.75 billion
Growth Rate	CAGR of 8.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nuclear Medicine Radioisotopes Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nuclear Medicine Radioisotopes Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nuclear Medicine Radioisotopes Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nuclear Medicine Radioisotopes Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Theranostics In Oncology Care

4.2.2 Growing Demand For Pet And Spect Imaging Procedures

4.2.3 Increased Use Of Targeted Alpha And Beta Emitters

4.2.4 Expansion Of Nuclear Medicine In Cardiology And Neurology

4.2.5 Strengthening Focus On Domestic Radioisotope Production

5. Nuclear Medicine Radioisotopes Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Specialty Clinics

5.4 Cancer Treatment Centers

5.5 Education And Research Institutes

6. Nuclear Medicine Radioisotopes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nuclear Medicine Radioisotopes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nuclear Medicine Radioisotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nuclear Medicine Radioisotopes Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nuclear Medicine Radioisotopes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nuclear Medicine Radioisotopes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nuclear Medicine Radioisotopes Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nuclear Medicine Radioisotopes Market Segmentation

9.1. Global Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types

9.2. Global Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiology, Thyroid, Neurology, Other Applications

9.3. Global Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users

9.4. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Technetium-99m (Tc-99m), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)

9.5. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Thallium-201 (Tl-201), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Thallous Chloride Tl-201, Thallium-201 For Cardiac Imaging

9.6. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-123 (I-123), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)

9.7. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Fluorine-18, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging

9.8. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Rubidium-82 (Rb-82), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging

9.9. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-131 (I-131), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment

9.10. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Lutetium-177 (Lu-177), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment

9.11. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Radium-223 (Ra-223) And Alpharadin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ra-223 Dichloride (Xofigo), Alpharadin For Bone Metastasis Treatment

9.12. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)

10. Nuclear Medicine Radioisotopes Market Regional And Country Analysis

10.1. Global Nuclear Medicine Radioisotopes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nuclear Medicine Radioisotopes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nuclear Medicine Radioisotopes Market

11.1. Asia-Pacific Nuclear Medicine Radioisotopes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nuclear Medicine Radioisotopes Market

12.1. China Nuclear Medicine Radioisotopes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nuclear Medicine Radioisotopes Market

13.1. India Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nuclear Medicine Radioisotopes Market

14.1. Japan Nuclear Medicine Radioisotopes Market Overview

14.2. Japan Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nuclear Medicine Radioisotopes Market

15.1. Australia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nuclear Medicine Radioisotopes Market

16.1. Indonesia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nuclear Medicine Radioisotopes Market

17.1. South Korea Nuclear Medicine Radioisotopes Market Overview

17.2. South Korea Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nuclear Medicine Radioisotopes Market

18.1. Taiwan Nuclear Medicine Radioisotopes Market Overview

18.2. Taiwan Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nuclear Medicine Radioisotopes Market

19.1. South East Asia Nuclear Medicine Radioisotopes Market Overview

19.2. South East Asia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nuclear Medicine Radioisotopes Market

20.1. Western Europe Nuclear Medicine Radioisotopes Market Overview

20.2. Western Europe Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nuclear Medicine Radioisotopes Market

21.1. UK Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nuclear Medicine Radioisotopes Market

22.1. Germany Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nuclear Medicine Radioisotopes Market

23.1. France Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nuclear Medicine Radioisotopes Market

24.1. Italy Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nuclear Medicine Radioisotopes Market

25.1. Spain Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nuclear Medicine Radioisotopes Market

26.1. Eastern Europe Nuclear Medicine Radioisotopes Market Overview

26.2. Eastern Europe Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nuclear Medicine Radioisotopes Market

27.1. Russia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nuclear Medicine Radioisotopes Market

28.1. North America Nuclear Medicine Radioisotopes Market Overview

28.2. North America Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nuclear Medicine Radioisotopes Market

29.1. USA Nuclear Medicine Radioisotopes Market Overview

29.2. USA Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nuclear Medicine Radioisotopes Market

30.1. Canada Nuclear Medicine Radioisotopes Market Overview

30.2. Canada Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nuclear Medicine Radioisotopes Market

31.1. South America Nuclear Medicine Radioisotopes Market Overview

31.2. South America Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nuclear Medicine Radioisotopes Market

32.1. Brazil Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nuclear Medicine Radioisotopes Market

33.1. Middle East Nuclear Medicine Radioisotopes Market Overview

33.2. Middle East Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nuclear Medicine Radioisotopes Market

34.1. Africa Nuclear Medicine Radioisotopes Market Overview

34.2. Africa Nuclear Medicine Radioisotopes Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nuclear Medicine Radioisotopes Market Regulatory and Investment Landscape

36. Nuclear Medicine Radioisotopes Market Competitive Landscape And Company Profiles

36.1. Nuclear Medicine Radioisotopes Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Nuclear Medicine Radioisotopes Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Nuclear Medicine Radioisotopes Market Company Profiles

36.3.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GE HealthCare Technologies Overview, Products and Services, Strategy and Financial Analysis

36.3.5. BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Nuclear Medicine Radioisotopes Market Other Major And Innovative Companies

Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczacibasi-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc.

38. Global Nuclear Medicine Radioisotopes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nuclear Medicine Radioisotopes Market

40. Nuclear Medicine Radioisotopes Market High Potential Countries, Segments and Strategies

40.1 Nuclear Medicine Radioisotopes Market In 2030 - Countries Offering Most New Opportunities

40.2 Nuclear Medicine Radioisotopes Market In 2030 - Segments Offering Most New Opportunities

40.3 Nuclear Medicine Radioisotopes Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Nuclear Medicine Radioisotopes Market, Overview Of Key Products - Product Examples

Table 2: Global Nuclear Medicine Radioisotopes Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Nuclear Medicine Radioisotopes Market, Supply Chain Analysis

Table 4: Global Nuclear Medicine Radioisotopes Market, Major Raw Material Providers

Table 5: Global Nuclear Medicine Radioisotopes Market, Major Resource Providers

Table 6: Global Nuclear Medicine Radioisotopes Market, Major Manufacturers (Suppliers)

Table 7: Global Nuclear Medicine Radioisotopes Market, Major Distributors And Channel Partners

Table 8: Global Nuclear Medicine Radioisotopes Market, Key Technologies & Future Trends

Table 9: Global Nuclear Medicine Radioisotopes Market, Major Trends

Table 10: Global Nuclear Medicine Radioisotopes Market, Major End Users

Table 11: Global Nuclear Medicine Radioisotopes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Nuclear Medicine Radioisotopes Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Nuclear Medicine Radioisotopes Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Nuclear Medicine Radioisotopes Market - TAM, US$ Billion, 2025

Table 15: Global Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Technetium-99m (Tc-99m), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Thallium-201 (Tl-201), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-123 (I-123), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Fluorine-18, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Rubidium-82 (Rb-82), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-131 (I-131), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Lutetium-177 (Lu-177), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Radium-223 (Ra-223) And Alpharadin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Nuclear Medicine Radioisotopes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Global Nuclear Medicine Radioisotopes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: China, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: India, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Taiwan, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: South East Asia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: UK, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: France, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: North America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: USA, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: South America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 101: Global Nuclear Medicine Radioisotopes Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 102: Global Nuclear Medicine Radioisotopes Market - Company Scoring Matrix

Table 103: Cardinal Health Inc. Financial Performance

Table 104: Bayer AG Financial Performance

Table 105: Siemens Healthineers AG Financial Performance

Table 106: GE HealthCare Technologies Financial Performance

Table 107: BWX Technologies Inc. Financial Performance

Table 108: Global Nuclear Medicine Radioisotopes Market, Competitive Benchmarking (In USD Billions)

Table 109: Global Nuclear Medicine Radioisotopes Market, Competitive Dashboard

Table 110: Global Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 111: Global, Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 112: Global, Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 113: Global, Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Nuclear Medicine Radioisotopes Market, Overview Of Key Products - Product Examples

Figure 2: Global Nuclear Medicine Radioisotopes Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Nuclear Medicine Radioisotopes Market, Supply Chain Analysis

Figure 4: Global Nuclear Medicine Radioisotopes Market, Major Raw Material Providers

Figure 5: Global Nuclear Medicine Radioisotopes Market, Major Resource Providers

Figure 6: Global Nuclear Medicine Radioisotopes Market, Major Manufacturers (Suppliers)

Figure 7: Global Nuclear Medicine Radioisotopes Market, Major Distributors And Channel Partners

Figure 8: Global Nuclear Medicine Radioisotopes Market, Key Technologies & Future Trends

Figure 9: Global Nuclear Medicine Radioisotopes Market, Major Trends

Figure 10: Global Nuclear Medicine Radioisotopes Market, Major End Users

Figure 11: Global Nuclear Medicine Radioisotopes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Nuclear Medicine Radioisotopes Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Nuclear Medicine Radioisotopes Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Nuclear Medicine Radioisotopes Market - TAM, US$ Billion, 2025

Figure 15: Global Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Technetium-99m (Tc-99m), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Thallium-201 (Tl-201), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-123 (I-123), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Fluorine-18, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Rubidium-82 (Rb-82), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-131 (I-131), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Lutetium-177 (Lu-177), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Radium-223 (Ra-223) And Alpharadin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Nuclear Medicine Radioisotopes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Global Nuclear Medicine Radioisotopes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: China, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: India, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Taiwan, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: South East Asia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: UK, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: France, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: North America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: USA, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: South America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 101: Global Nuclear Medicine Radioisotopes Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 102: Global Nuclear Medicine Radioisotopes Market - Company Scoring Matrix

Figure 103: Cardinal Health Inc. Financial Performance

Figure 104: Bayer AG Financial Performance

Figure 105: Siemens Healthineers AG Financial Performance

Figure 106: GE HealthCare Technologies Financial Performance

Figure 107: BWX Technologies Inc. Financial Performance

Figure 108: Global Nuclear Medicine Radioisotopes Market, Competitive Benchmarking (In USD Billions)

Figure 109: Global Nuclear Medicine Radioisotopes Market, Competitive Dashboard

Figure 110: Global Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 111: Global, Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 112: Global, Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 113: Global, Nuclear Medicine Radioisotopes Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Refrigerated Display Cases Market Report 2026 - Global Outlook – By Type ( Plug-In, Semi Plug-In, Remote), By Design ( Vertical, Horizontal, Hybrid), By Application ( Retail Stores, Restaurants And Hotels, Other Applicat...

3D Display Market Report 2026 - Global Outlook – By Product ( Volumetric, Stereoscopic), By Technology ( Digital Light Processing, Organic Light-Emitting Diode), By Access Methods ( Conventional or Screen-based Display, ...

Note Sorter Market Report 2026 - Global Outlook – By Sorter Type (Small-Sized Note Sorter, Medium-Sized Note Sorter, Large-Sized Note Sorter), By Enterprise Size (Large Enterprises, Small And Medium Enterprises ), By End...

Radiotherapy Devices Market Report 2026 - Global Outlook – By Product Type (External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices), By Application (Skin Cancer, Breast Cancer, Prosta...

Bionematicides Market Report 2026 - Global Outlook – By Type (Microbials, Biochemical), By Form (Dry Bionematicides, Liquid Bionematicides), By Crop (Cotton, Corn, Soybean, Fruits And Vegetables, Other Crops), By Applica...

Nuclear Imaging Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (SPECT Systems, PET Systems, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, Other Applications),...

Urology Medical Lasers Market Report 2026 - Global Outlook – By Laser Type (Holmium Laser System, Diode Laser System, Thulium Laser System, Other Laser Types), By Application (Benign Prostatic Hyperplasia (BPH), Urolithi...

Frequently Asked Questions

How big is the Nuclear Medicine Radioisotopes Market?

The Nuclear Medicine Radioisotopes market was valued at $8.85 billion in 2025, increased to $9.58 billion in 2026, and is projected to reach $12.75 billion by 2030.

What is the Nuclear Medicine Radioisotopes market growth?

The global Nuclear Medicine Radioisotopes market is expected to grow at a CAGR of 7.4% from 2026 to 2035 to reach $12.75 billion by 2035.

Who are the key players in Nuclear Medicine Radioisotopes market?

Some Key Players in the Nuclear Medicine Radioisotopes market Include, Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings I

Major trend in this market includes: Next-Generation Radiopharmaceuticals Accelerate The Future Of Precision Medicine. For further insights on this market. request a sample here

North America was the largest region in the nuclear medicine radioisotopes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market rep

Book your 30 minutes free consultation with our research experts

Contact Us